Senior woman header
Senior woman header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test™ from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
October 15, 2020

Orthostatic Hypotension May Be An Early Sign of Parkinson’s Disease

Orthostatic hypotension (OH), a drop in blood pressure upon standing that might cause you to…
Insights
October 2, 2020

The Story of Robin Williams Brings the Terror of Dementia With Lewy Bodies to Light

A New Test From CND Life Sciences Helps Detect It
Insights
May 1, 2020

Why Diagnostic Testing Reliability Matters

Perhaps there has been no other time in the last century when the topic of…

Check out press releases, news alerts and coverage of CND happenings.

In the News
October 26, 2020

CND Life Sciences Awarded NIH SBIR Grant to Advance Diagnostic Technology for Neurodegenerative Diseases

Grant Supports the Continued Validation and Enhancement of the Syn-One Test™ To Help Physicians Diagnose…
In the News
September 9, 2020

Response to the S4 Study Results in Neurology

A group of international experts responded to the publication of the recent Systemic Synuclein Sampling…
In the News
August 31, 2020

CND Founders’ Research in the New York Times

Drs. Christopher Gibbons and Roy Freeman--two of the founders of CND Life Sciences who also…
CND CASE STUDIES

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit